David N Mishol
Dr Mishol, principal, is an economist who specialises in competition, securities, econometrics, microeconomic theory, statistics, healthcare and pharmacoeconomics. He has provided consulting support to counsel throughout many phases of litigation, including preparation of expert deposition and trial testimony; development, presentation and review of pretrial discovery; and critique of analyses of opposing experts. He has served as an expert witness and worked with leading academic scholars, providing economic and damages analysis on matters involving cartels and mergers; analysis of market definition issues in a variety of industries; economic, financial and quantitative analyses related to allegations of securities fraud in Rule 10b-5, ERISA and structured finance matters; and economic, quantitative and damages analyses in the pharmaceutical industry. Outside of litigation, Dr Mishol has used sophisticated econometric modelling techniques to help major pharmaceutical companies make product entry decisions by assessing the impact of market factors such as product quality, pricing, patent expiration and regulatory policy on the demand for prescription pharmaceuticals.Dr Mishol holds a BA in economics from Brandeis University and a PhD in economics from Boston College.